(Q39886525)

15 September 2017

title

Atomoxetine versus stimulants in the community treatment of children with ADHD: an electronic diary study (English)

1 reference

15 September 2017

1 reference

2

Barbara Henker

1 reference

15 September 2017

Carol K Whalen

1

1 reference

15 September 2017

Sharon S Ishikawa

3

1 reference

15 September 2017

Natasha A Emmerson

4

1 reference

15 September 2017

Ralph Swindle

5

1 reference

15 September 2017

Joseph A Johnston

6

1 reference

15 September 2017

publication date

1 January 2010

1 reference

Journal of Attention Disorders

15 September 2017

published in

1 reference

15 September 2017

volume

13

1 reference

15 September 2017

issue

4

1 reference

15 September 2017

page(s)

391-400

1 reference

Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1087054708325118

Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708325118

Despite technical problems personal digital assistants outperform pen and paper when collecting patient diary data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708325118

Informant discrepancies in the assessment of childhood psychopathology: a critical review, theoretical framework, and recommendations for further study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708325118

Postmarketing surveillance--lack of vigilance, lack of trust.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708325118

Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708325118

Longitudinal relations between parenting and child adjustment in young children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708325118

Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708325118

Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708325118

Abuse liability assessment of atomoxetine in a drug-abusing population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708325118

Incremental validity in the psychological assessment of children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708325118

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708325118

Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708325118

Outcomes of OROS methylphenidate compared with atomoxetine in children with ADHD: a multicenter, randomized prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708325118

Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708325118

Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708325118

Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708325118

National trends in the treatment of attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708325118

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708325118

Ecological momentary assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708325118

Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708325118

Patient non-compliance with paper diaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708325118

Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708325118

Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708325118

A randomized, placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708325118

An electronic diary study of contextual triggers and ADHD: get ready, get set, get mad.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708325118

Toward mapping daily challenges of living with ADHD: maternal and child perspectives using electronic diaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708325118

A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708325118

21 January 2018

Identifiers

DOI

10.1177/1087054708325118

1 reference

15 September 2017

1 reference